文献速递免疫规划传染病防控与疫情报告

兰州羔羊轮状病毒疫苗预防5岁以下儿童胃肠炎的效果

Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age.
PubMed 文献 · Vaccine · 2019-05-20

该研究基于2015—2017年北京7家医院监测系统,采用病例对照设计评估兰州羔羊轮状病毒(LLR)疫苗对5岁以下儿童实验室确诊轮状病毒感染的疫苗效果(VE)。共纳入598例病例和1766例对照,1剂次相对于0剂次的调整VE为34.9%(95%CI 5.3—55.3),接种者临床表现较轻。

要点

  • 1剂次LLR疫苗对5岁以下儿童轮状病毒感染的调整VE为34.9%(95%CI 5.3—55.3)。
  • 接种者出现水样便和腹泻超过5天的风险较低(OR分别为0.42和0.47)。
  • 建议在1岁内完成全部3剂次接种。

核心结论

  • LLR疫苗对轮状病毒病具有保护作用,接种儿童临床表现较轻。

研究设计与样本

  • 基于北京市7家医院监测系统的病例对照研究,纳入2015年10月1日至2017年3月31日5岁以下儿童,以轮状病毒阴性病例为对照,共598例病例和1766例对照。

主要发现

  • 2015—2017年北京5岁以下儿童LLR疫苗平均覆盖率为10.8%。
  • 1剂次相对于0剂次的调整VE为34.9%(95%CI 5.3—55.3)。
  • 严重程度评分≥11的患者调整VE为87.7%(95%CI 32.7—97.8)。
  • 2—35月龄儿童调整VE为36.2%(95%CI 4.7—57.3),针对G9轮状病毒感染调整VE为40.8%(95%CI 7.8—61.9)。
  • 接种病例出现水样便(OR=0.42)和腹泻超过5天(OR=0.47)的可能性低于未接种病例。

临床怎么用

  • LLR疫苗可用于预防5岁以下儿童轮状病毒感染,建议在1岁内完成全部3剂次接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lanzhou Lamb rotavirus (LLR) vaccine was licensed in China in 2000. It was the only vaccine available in private market before 2018. However, the data about the post-marketing effectiveness is very limited. To assess the vaccine effectiveness (VE), we conducted a case-control study based on the hospital surveillance system in Beijing from 2015 to 2017. METHODS: Seven hospitals located in seven districts in Beijing, from October 1, 2015, to March 31, 2017, were included. The VE of LLR vaccine was assessed in laboratory-confirmed rotavirus infection among children younger than five years old through a case-control design, using rotavirus-negative cases as controls. LLR vaccination was documented from a vaccination registry. VE was estimated adjusting for age group, gender, study site, the month of illness onset and interval days between illness onset to sampling through a logistic regression model. RESULTS: A total of 598 cases and 1766 controls were included in this study. The vaccine average coverage rate during 2015-2017 among children younger than five years old was 10.8% in Beijing. The adjusted VE for LLR vaccine of 1 dose versus 0 dose was 34.9% (95%CI, 5.3-55.3). We also obtained the adjusted VE of 87.7% (95%CI, 32.7-97.8) for patients with the severity score ≥11, 36.2% (95%CI, 4.7-57.3) for children of 2-35 months age group and 40.8% (95%CI, 7.8-61.9) against G9 rotavirus infection. Vaccinated cases were less likely to have watery stool (OR = 0.42) and have diarrhea longer than 5 days (OR = 0.47) than unvaccinated cases. DISCUSSION: LLR vaccine conferred protection against rotavirus disease. Children who were vaccinated presented with less severe clinical manifestations. An immunization schedule of receiving all three doses in the first year should be preferred.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Li J, Zhang Y, Yang Y, et al. Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age. Vaccine. 2019. PMID: 31122857. doi:10.1016/j.vaccine.2019.03.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。